Weight Loss Options

GLP-1 receptor agonists, which work by stimulating the release of insulin and reducing the production of glucagon in the body. This helps to lower blood sugar levels and can also lead to weight loss.

Tirzepatide is a dual GLP-1/GIP receptor agonist, while semaglutide is a GLP-1 receptor agonist. GIP is another hormone that is released after eating and helps to regulate appetite and digestion. By targeting both GLP-1 and GIP receptors, tirzepatide may be more effective at reducing appetite and weight than semaglutide.

AOD-9604 is a synthetic peptide analogue of the lipolytic domain of hGH. AOD-9604 is thought to work by stimulating lipolysis, which leads to increased fat burning.

This combination results in a more sustained release of Growth Hormone, which can lead to increased muscle mass, improved body composition, and anti-aging benefits.

Sermorelin/Ipamorelin is generally considered to be less potent than CJC/Ipamorelin, and is often used in milder cases of GH deficiency or for anti-aging purposes.